Fig. 2From: A PK/PD model for the evaluation of clinical rifaximin dosage for the treatment of dairy cow mastitis induced by Escherichia coliThe curve of concentration vs time of rifaximin in CD-1 mouse mammary glands following intramammary administration doses of 50, 100, 200, and 400 µg/gland (n = 6)Back to article page